Testosterone Replacement Therapy (TRT)
This article is a placeholder. Only its topic and title are committed at this stage; the substantive body will be drafted in a future cycle of the engine.
Exogenous testosterone for hypogonadal men, with attention to cardiovascular safety (TRAVERSE, NEJM 2023), prostate-cancer signal, and fertility preservation. Endocrine Society guidelines; the candidate-vs-non-candidate framing; the difference between physiologic replacement and supraphysiologic dosing typical of performance-clinic protocols.